Functional MRI (fMRI) for Biomedical Engineers: Principles, Components, Applications, and Emerging Innovations

Functional magnetic resonance imaging (fMRI) stands as one of the most transformative tools in modern neuroimaging, enabling biomedical engineers and clinical researchers to observe the living, working brain in real time without ionizing radiation or surgical intervention. By detecting subtle fluctuations in blood oxygenation that accompany neural firing, fMRI bridges the gap between cellular metabolism and whole-brain cognitive mapping. Since its emergence in the early 1990s, the technology has grown from a research curiosity into a clinical and investigational cornerstone, informing everything from pre-surgical planning to fundamental neuroscience. For biomedical engineers, understanding fMRI demands fluency in MR physics, hemodynamic physiology, signal processing, and hardware design — a multidisciplinary convergence that makes fMRI both uniquely challenging and extraordinarily rewarding to work with. This article provides a structured, engineering-focused overview of fMRI: its physical underpinnings, core components, variant acquisition strategies, and the clinical contexts in which it delivers irreplaceable value. Comparisons with complementary modalities such as CT scanners and SPECT are drawn where relevant to contextualize fMRI’s unique capabilities.

1. What is Functional MRI (fMRI)?

Functional magnetic resonance imaging (fMRI) is a noninvasive neuroimaging technique that measures and maps regional brain activity by detecting changes in blood oxygenation and flow that arise as a direct consequence of neural activity. Unlike structural MRI, which provides static anatomical detail, fMRI captures the dynamic physiological state of the brain during cognitive tasks, sensory stimulation, motor execution, or even rest. The result is a four-dimensional dataset — three spatial dimensions plus time — that allows engineers and neuroscientists to identify which brain regions are engaged by specific processes and how those regions communicate with one another.

The conceptual roots of fMRI extend back to William James’ 1890 proposition that regional cerebral blood flow is a reliable surrogate for local neural activity. For decades, this hypothesis remained theoretical, but in 1948 researchers achieved the first noninvasive quantification of cerebral blood flow in conscious humans using Fick’s principle. The technological leap to fMRI itself occurred in the early 1990s: the first fMRI scan performed during active intellectual stimulation was conducted in 1991, leveraging existing MRI hardware to map cerebral blood volume under both resting and cognitively stimulated conditions. This milestone demonstrated that conventional MRI scanners could, with appropriate pulse sequence design and post-processing, be repurposed for functional brain mapping without any exogenous contrast agent or ionizing radiation — a decisive advantage over positron emission tomography (PET) and SPECT imaging that had previously dominated functional neuroimaging.

The primary contrast mechanism exploited by fMRI is the blood oxygen level–dependent (BOLD) effect, which will be explored in detail in Section 3. In brief, BOLD fMRI capitalizes on the differential magnetic susceptibility of oxygenated hemoglobin (HbO₂, diamagnetic) versus deoxygenated hemoglobin (Hb, paramagnetic). When neurons fire, a cascade of hemodynamic events ultimately delivers more oxygenated blood to the active region than is metabolically consumed, transiently reducing local Hb concentration and increasing the local MR signal. It is this small but reproducible signal fluctuation — typically on the order of 1% above baseline — that encodes the functional map of the brain.

2. Why is Functional MRI (fMRI) used?

fMRI occupies a unique position in the medical imaging landscape because it is the only widely available, noninvasive technique that can localize neural activity with millimeter-scale spatial resolution across the entire brain simultaneously, without introducing radioactive tracers or ionizing radiation. This combination of safety, spatial detail, and whole-brain coverage makes it invaluable across both clinical and research settings.

Clinical Applications

In the clinical domain, fMRI is most prominently used for pre-surgical brain mapping. Before resective surgery for epilepsy, brain tumors, or arteriovenous malformations, neurosurgeons require precise localization of eloquent cortex — the regions governing language, motor function, and memory. fMRI can identify these critical areas non-invasively, allowing surgical teams to plan resection boundaries that maximize tumor removal while minimizing functional deficits. This application has progressively reduced reliance on the more invasive intraoperative cortical stimulation or the Wada test. Additionally, fMRI is used to assess neurological recovery trajectories after stroke, evaluate consciousness levels in minimally conscious state patients, and investigate psychiatric conditions including depression, schizophrenia, and anxiety disorders.

Research Applications

In the research context, fMRI has become the workhorse of cognitive neuroscience. It enables systematic mapping of functional specialization — confirming, for instance, that Broca’s area is engaged during language production, or that the fusiform face area activates preferentially to human faces. Beyond task-based paradigms, resting-state fMRI has revealed intrinsic functional networks that persist in the absence of deliberate cognitive engagement, including the default mode network, the salience network, and the frontoparietal control network. These connectivity patterns are being actively investigated as potential biomarkers for neurological and psychiatric disease. For biomedical engineers, understanding the clinical demands that fMRI must satisfy — spatial precision for surgical planning, temporal fidelity for cognitive paradigms, and robustness for patient populations — is essential when designing acquisition hardware, sequences, or post-processing pipelines.

3. How does Functional MRI (fMRI) work in general?

At its physical core, fMRI operates on the same principles as conventional MRI. A powerful static magnetic field (B₀), typically ranging from 1.5 T to 7 T in clinical and research systems — as discussed in our article on MRI field strengths from 1.5T to 7T — aligns the magnetic moments of hydrogen protons in tissue water. Radiofrequency (RF) pulses at the Larmor frequency tip these protons out of equilibrium. As protons relax back to alignment, they emit RF energy that is spatially encoded using gradient magnetic fields and detected by receiver coils. The contrast within the resulting images reflects differences in proton density and relaxation times (T1, T2, T2*) across tissue types.

The BOLD Mechanism and Neurovascular Coupling

fMRI’s functional sensitivity derives from the T2*-weighted BOLD contrast mechanism. The sequence of events underpinning a BOLD response begins the moment neurons increase their firing rate in response to a stimulus or task. Elevated neural activity raises the local cerebral metabolic rate of oxygen (CMRO₂), drawing down nearby oxygen stores. Chemical byproducts of metabolism — including CO₂, nitric oxide (NO), and hydrogen ions (H⁺) — act as vasoactive signals that trigger dilation of upstream arteriolar sphincters. This vasodilatory response increases cerebral blood flow (CBF) and cerebral blood volume (CBV) to the active region within one to two seconds. Crucially, the hemodynamic overshoot delivers substantially more oxygenated blood than is required to meet the elevated CMRO₂. The net result is a local reduction in paramagnetic deoxyhemoglobin concentration, which decreases field inhomogeneity around blood vessels and prolongs T2* relaxation times — producing an increase in T2*-weighted signal intensity that constitutes the positive BOLD response. This entire chain of events, from neural firing to vascular response, is termed neurovascular coupling and is the physiological substrate that fMRI measures. It is important for engineers to appreciate that fMRI does not measure electrical activity directly; it measures a hemodynamic proxy that introduces temporal blurring relative to the underlying electrophysiology.

The Hemodynamic Response Function

The canonical BOLD response to a brief neural event follows a stereotyped waveform known as the hemodynamic response function (HRF). After stimulus onset, the signal may exhibit a small initial dip (reflecting the transient Hb buildup before CBF increases), followed by a peak at approximately 5–6 seconds, and then an undershoot below baseline that can persist for 20–30 seconds before returning to equilibrium. The HRF is modeled mathematically — commonly as a difference of two gamma functions — and convolved with the experimental task design to generate predicted BOLD time series for statistical analysis. Understanding the HRF shape is critical when designing fMRI paradigms and interpreting activation maps, because events spaced too closely in time will produce overlapping hemodynamic responses that are difficult to deconvolve.

4. What are the main components of Functional MRI (fMRI)?

An fMRI system integrates several interdependent hardware and software subsystems. Each component presents specific engineering challenges and contributes distinctly to image quality and functional sensitivity.

Main Magnet

The main superconducting magnet generates the static B₀ field. Superconducting wire coils, immersed in liquid helium and carrying substantial current, produce fields of 1.5 T, 3 T, or 7 T in clinical and research systems. Field homogeneity across the imaging volume is paramount: spatial variations in B₀ distort the BOLD signal and degrade image geometry. Higher field strengths yield greater BOLD contrast-to-noise ratio (CNR) because the susceptibility difference between HbO₂ and Hb scales approximately linearly with B₀, while the baseline signal-to-noise ratio increases — a key engineering trade-off to consider when specifying scanner platforms for fMRI research.

Gradient Coils

Three sets of gradient coils (X, Y, Z) superimpose linearly varying magnetic fields on B₀ to provide spatial encoding: slice selection, phase encoding, and frequency encoding. For fMRI, gradient performance — specifically maximum amplitude (mT/m) and slew rate (T/m/s) — determines the achievable echo-planar imaging (EPI) readout speed and susceptibility to eddy currents and image distortion. Whole-brain EPI volumes are typically acquired in 2–3 seconds using conventional systems, though simultaneous multi-slice (SMS) acceleration can reduce this to sub-second volume acquisition rates, improving temporal resolution for resting-state connectivity analyses.

Radiofrequency System

The RF transmitter generates precisely calibrated pulses at the proton Larmor frequency to excite magnetization. The receiver system — typically a multi-channel phased-array head coil — detects the emitted MR signal from the brain. High-density receiver arrays (32, 64, or 128 channels) improve signal-to-noise ratio and enable parallel imaging acceleration (e.g., GRAPPA, SENSE), which reduces EPI echo train length and thereby minimizes geometric distortion and T2* blurring in BOLD images.

Pulse Sequence and Acquisition Electronics

The pulse sequence spectrometer coordinates the timing of RF pulses and gradient waveforms with microsecond precision. For fMRI, the gradient-echo EPI sequence is the near-universal choice because it maximizes T2* weighting and whole-brain temporal sampling efficiency. Key sequence parameters — echo time (TE), flip angle, repetition time (TR), and voxel size — are tuned to optimize BOLD sensitivity for the target brain region and field strength. The raw k-space data acquired by the spectrometer are transferred to a reconstruction computer that applies Fourier transforms, phase corrections, and parallel imaging algorithms to produce magnitude images.

Stimulus Delivery and Physiological Monitoring

Task-based fMRI requires synchronised stimulus delivery — visual displays (MRI-compatible back-projection or fiber-optic systems), auditory stimuli (MRI-compatible headphones with pneumatic or electrostatic drivers), or tactile/motor apparatus — all of which must be MR-safe and electromagnetically shielded. Physiological monitoring hardware (pulse oximeters, respiratory bellows) records cardiac and respiratory cycles whose fluctuations contaminate BOLD signals; these recordings feed retrospective correction algorithms such as RETROICOR. The integration of these systems with scanner triggering logic is a substantial biomedical engineering task in any fMRI installation.

Data Processing and Storage Infrastructure

fMRI generates large volumetric time series datasets requiring robust storage and processing infrastructure. Pipelines typically encompass slice timing correction, motion realignment, spatial normalization to standard atlases (e.g., MNI space), spatial smoothing, and general linear model (GLM) statistical analysis. Integration with hospital Picture Archiving and Communication Systems (PACS) via DICOM standards ensures that functional imaging data are archived, retrievable, and interoperable with other modalities in the clinical workflow.

5. What types/variants of Functional MRI (fMRI) exist?

fMRI is not a monolithic technique. A spectrum of acquisition paradigms, contrast mechanisms, and experimental designs has evolved to address specific neuroscientific and clinical questions. The table below summarizes the major variants that biomedical engineers are likely to encounter.

Task-Based vs. Resting-State Paradigms

Task-based fMRI asks participants to perform specific cognitive, motor, or sensory tasks while in the scanner, enabling direct localization of function. It remains the clinical standard for pre-surgical mapping. Resting-state fMRI, by contrast, acquires data while participants lie quietly with no explicit task, and relies on the spatiotemporal coherence of spontaneous BOLD fluctuations to infer functional connectivity between brain regions. Resting-state approaches are particularly valuable for patient populations who cannot perform tasks reliably — including children, patients with disorders of consciousness, and individuals with severe motor or language impairments. From an engineering perspective, resting-state data are more susceptible to physiological noise confounds (cardiac pulsatility, respiratory motion) and head movement artifacts, demanding rigorous preprocessing.

Arterial Spin Labeling as a Complement to BOLD

Arterial spin labeling (ASL) fMRI uses magnetically labeled water protons in inflowing arterial blood as an endogenous tracer to quantify cerebral blood flow in absolute physiological units (mL/100g/min). Unlike BOLD, ASL provides a more direct and quantitative measure of perfusion and does not suffer from the venous weighting that biases BOLD activation maps toward draining veins rather than the site of neural activity. ASL is therefore increasingly favored for longitudinal studies and pharmacological challenges where absolute CBF values are needed, complementing BOLD’s superior sensitivity and temporal resolution. This trade-off between quantitative perfusion measurement and high-sensitivity functional mapping is an important design consideration for biomedical engineers developing fMRI protocols, analogous to the trade-offs encountered when selecting between modalities such as Doppler ultrasound and contrast-enhanced methods for vascular assessment in other organ systems.

6. What are the main benefits of Functional MRI (fMRI)?

Functional MRI has transformed both neuroscience research and clinical medicine by offering a uniquely powerful window into living brain function. For biomedical engineers, understanding these benefits is essential when evaluating fMRI as a diagnostic or research tool and when comparing it with complementary modalities such as SPECT or CT scanning.

Non-Invasive Assessment of Neural Function

Perhaps fMRI’s most significant advantage is that it enables real-time mapping of brain activity without ionising radiation, contrast injections, or surgical intervention. Unlike positron emission tomography (PET), which requires radioactive tracers, fMRI relies entirely on endogenous haemodynamic signals. This non-invasiveness makes repeated longitudinal studies feasible—patients can be scanned multiple times to track disease progression or treatment response without cumulative radiation burden.

High Spatial Resolution and Whole-Brain Coverage

Modern fMRI systems routinely achieve voxel sizes in the 1–4 mm³ range, allowing investigators to localise activation to specific cortical areas, subcortical nuclei, and white-matter tracts simultaneously. Whole-brain echo-planar imaging (EPI) acquisitions can capture this spatial detail across the entire cerebral volume within a single TR (repetition time), providing a global snapshot of functional architecture that no other non-invasive modality can match at comparable resolution.

Pre-Surgical Planning and Clinical Decision Support

Clinically, task-based fMRI is indispensable for pre-surgical mapping of eloquent cortex—identifying language, motor, and memory regions before tumour resection or epilepsy surgery. By visualising which areas are functionally critical, neurosurgeons can plan resection margins that maximise tumour removal while minimising neurological deficits. This application alone has driven widespread adoption of fMRI in tertiary neurosurgical centres worldwide.

Versatility Across Research and Clinical Domains

Beyond surgery, fMRI has broad utility in psychiatry (mapping altered connectivity in depression, schizophrenia, and PTSD), cognitive neuroscience (studying memory, attention, and decision-making), pain research, and pharmaceutical trials where treatment-induced changes in brain activation serve as biomarkers. Resting-state fMRI further extends this versatility by requiring no active task from the patient—a significant advantage in paediatric or severely ill populations.

7. What are general risks or limitations?

Despite its considerable strengths, fMRI carries a range of technical, physiological, and practical limitations that biomedical engineers must account for during system design, data acquisition, and result interpretation.

Susceptibility Artefacts and Signal Distortion

The EPI sequences used in BOLD fMRI are highly susceptible to magnetic field inhomogeneities at air–tissue interfaces, particularly near the orbitofrontal cortex and temporal poles. These susceptibility artefacts can cause geometric distortion and signal dropout, rendering certain brain regions effectively unmappable without specialised field-map correction sequences or multi-echo acquisitions. Engineers designing acquisition protocols must carefully balance spatial resolution, echo time (TE), and field-map correction strategies.

Indirect and Delayed Neural Signal

The BOLD signal is an indirect proxy for neural activity, mediated through neurovascular coupling with an inherent haemodynamic lag of approximately 4–6 seconds from neural onset to peak response. This temporal blurring limits the ability to resolve rapid cognitive processes and introduces confounds when neurovascular coupling itself is altered—as occurs in stroke, tumours, or ageing populations where vascular reactivity may be impaired. Temporal resolution also remains inferior to electroencephalography (EEG) or magnetoencephalography (MEG).

Motion Sensitivity and Patient Compliance

Even sub-millimetre head motion during acquisition can corrupt BOLD time-series data, introducing spurious correlations and activation artefacts. This is particularly problematic in children, patients with movement disorders, or anxious individuals. Prospective motion correction hardware, post-hoc realignment algorithms, and motion scrubbing are standard mitigation strategies, but significant motion remains a leading cause of data exclusion in clinical and research studies.

MRI Safety Contraindications

Standard MRI safety considerations apply fully to fMRI. Patients with certain metallic implants (some cardiac pacemakers, cochlear implants, or ferromagnetic aneurysm clips), implanted electronic devices, or severe claustrophobia may not be suitable candidates. The strong static field, rapidly switched gradient fields, and radiofrequency pulses create a complex electromagnetic environment that biomedical engineers must evaluate carefully—particularly as implantable neurotechnology becomes more prevalent in potential fMRI populations. Thorough pre-scan screening protocols are non-negotiable.

8. How is Functional MRI (fMRI) evolving / recent innovations?

fMRI is one of the most rapidly advancing domains in biomedical imaging engineering. Convergent progress in magnet technology, computational methods, and real-time data processing is substantially expanding what the modality can achieve. Engineers working in this field should track developments across hardware, acquisition, and analysis layers simultaneously. Related advances in broader MRI hardware are discussed in our article on MRI technology from 1.5T to 7T and beyond.

Ultra-High Field Systems (7T and Beyond)

The increasing clinical and research deployment of 7 Tesla MRI systems offers substantially improved BOLD contrast-to-noise ratio compared with standard 3T platforms, enabling sub-millimetre spatial resolution that can resolve individual cortical layers and columns. This laminar and columnar fMRI capability opens entirely new experimental paradigms—allowing researchers to dissect excitatory and inhibitory connectivity within cortical circuits at a level previously accessible only through invasive electrophysiology. The FDA clearance of 7T systems for clinical use (Siemens MAGNETOM Terra) marks a pivotal regulatory milestone for translation.

Artificial Intelligence and Machine Learning Integration

Deep learning is transforming fMRI at multiple stages of the imaging pipeline. Convolutional neural networks (CNNs) now enable rapid image reconstruction from under-sampled k-space data (accelerated by techniques such as simultaneous multi-slice and compressed sensing), dramatically reducing scan times without sacrificing resolution. At the analysis stage, AI-driven brain decoding—predicting cognitive states or clinical diagnoses directly from BOLD activation patterns—is approaching clinical utility for applications ranging from brain–computer interfaces to psychiatric biomarker identification. Integration with PACS and DICOM infrastructure is becoming essential as fMRI datasets scale in size and complexity.

Real-Time fMRI and Neurofeedback

Real-time fMRI neurofeedback (rt-fMRI-NF) represents a paradigm shift from passive observation to active therapeutic intervention. Participants receive continuous feedback about their own brain activation through a visual or auditory interface and learn to self-regulate targeted regions or networks. Early clinical trials have demonstrated efficacy in depression, chronic pain, Parkinson’s disease, and addiction. The engineering challenges—achieving latencies of under 2 seconds from acquisition to feedback display, robust artefact rejection on the fly, and closed-loop adaptive paradigm control—place significant demands on both hardware and real-time software infrastructure.

Multimodal Fusion and Concurrent EEG–fMRI

Simultaneous EEG–fMRI acquisition combines EEG’s millisecond temporal resolution with fMRI’s millimetre spatial localisation, offering a synergistic window on brain dynamics. Engineering requirements are demanding: MRI-compatible EEG amplifiers, sophisticated gradient artefact and ballistocardiogram removal algorithms, and time-locked synchronisation hardware. Combined with advances in diffusion MRI tractography and MEG fusion, these multimodal approaches are steadily replacing single-modality paradigms in research centres, pushing toward comprehensive spatiotemporal brain mapping.

9. Key takeaways / tips for biomedical engineers

For biomedical engineers engaging with fMRI—whether in device development, clinical applications engineering, research, or regulatory affairs—the following practical considerations distil the most important technical and strategic insights from this overview.

Understand the Full Signal Chain

fMRI signal quality depends on every link in the chain: magnet homogeneity, gradient performance, RF coil design, pulse sequence parameters, patient preparation, and post-processing pipeline. A weakness at any node propagates into the final statistical maps. Engineers should develop fluency across all these domains rather than specialising exclusively in hardware or software in isolation. Pay particular attention to TE selection relative to local tissue T2* values when optimising BOLD sensitivity for specific brain regions.

Prioritise Motion Mitigation Strategies

Head motion is the single most common source of data loss and false-positive results in fMRI studies. When specifying or evaluating fMRI systems, rigorously assess the quality of prospective motion correction options, the vendor’s implementation of simultaneous multi-slice acceleration (which reduces TR and thus the time window for motion to corrupt data), and post-processing tools such as ICA-based denoising. For paediatric or clinical populations, budget additional protocol time for patient acclimatisation and consider MR-compatible motion-tracking hardware.

Navigate Safety and Regulatory Frameworks Carefully

fMRI system design and clinical deployment must comply with IEC 60601-2-33 (safety requirements for MR equipment), FDA 510(k) clearance pathways for clinical indications, and site-specific ACR–AAPM technical standards for fMRI quality assurance. When fMRI is used in conjunction with implanted devices or novel coil configurations, electromagnetic compatibility testing and specific absorption rate (SAR) monitoring become critical. Stay current with evolving FDA guidance on AI/ML-based software as a medical device (SaMD), which increasingly governs AI-assisted fMRI analysis tools.

Leverage Cross-Modality Expertise

fMRI does not exist in isolation. Familiarity with complementary imaging modalities—structural MRI, diffusion tensor imaging, SPECT, and CT—enriches the engineer’s ability to design multimodal protocols, interpret combined datasets, and advise clinical teams on the most appropriate imaging strategy for a given indication. Understanding PACS and DICOM standards is equally essential as fMRI data volumes continue to grow and integration with hospital informatics systems becomes mandatory.

References

1. Bandettini, P. A. (2012). Twenty years of functional MRI: The science and the stories. NeuroImage, 62(2), 575–588. https://pmc.ncbi.nlm.nih.gov/articles/PMC3073717/
2. Huettel, S. A., Song, A. W., & McCarthy, G. (2014). Functional Magnetic Resonance Imaging (3rd ed.). Sinauer Associates. [Standard textbook reference for fMRI physics and analysis.]
3. UC San Diego Center for Functional MRI. (n.d.). What is fMRI? https://fmri.ucsd.edu/Research/whatisfmri.html
4. The Open University / OpenLearn. (n.d.). How fMRI works. https://www.open.edu/openlearn/body-mind/health/health-sciences/how-fmri-works
5. Radiological Society of North America (RSNA) / RadiologyInfo.org. (2023). Functional MRI of the brain. https://www.radiologyinfo.org/en/info/fmribrain
6. Bandettini, P. A., & Cox, R. W. (2000). Event-related fMRI contrast when using constant interstimulus interval: Theory and experiment. Magnetic Resonance in Medicine, 43(4), 540–548. Available via PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC162295/
7. Cleveland Clinic. (2023). Functional MRI (fMRI). https://my.clevelandclinic.org/health/diagnostics/25034-functional-mri-fmri
8. Academic Medical & Surgical Journal. (2023). The history and continued evolution of functioning magnetic resonance imaging technology (fMRI). https://academic-med-surg.scholasticahq.com/article/123287
9. Ogawa, S., Lee, T. M., Kay, A. R., & Tank, D. W. (1990). Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceedings of the National Academy of Sciences, 87(24), 9868–9872. [Foundational BOLD contrast paper.]
10. Logothetis, N. K. (2008). What we can do and what we cannot do with fMRI. Nature, 453(7197), 869–878. [Key reference for neurovascular coupling limitations.]
11. International Electrotechnical Commission. (2015). IEC 60601-2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis (3rd ed., Amendment 2). Geneva: IEC.
12. U.S. Food and Drug Administration. (2021). Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices: Guidance for Industry and FDA Staff. FDA. [Regulatory guidance for MRI/fMRI device classification.]
13. American College of Radiology (ACR). (2022). ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Magnetic Resonance Imaging (MRI) Equipment. ACR.
14. Siemens Healthineers. (2023). MAGNETOM Terra 7T MRI system technical specifications. https://www.siemens-healthineers.com/magnetic-resonance-imaging/7t-mri-scanner
15. Biomed Devices. (2024). From 1.5T to 7T and beyond: How MRI technology and AI are reshaping diagnostics. https://biomedevices.com/from-1-5t-to-7t-and-beyond-how-mri-technology-and-ai-are-reshaping-diagnostics/
16. Biomed Devices. (2024). A comprehensive guide to PACS for biomedical engineers. https://biomedevices.com/a-comprehensive-guide-to-pacs-for-biomedical-engineers-covering-dicom-components-types-clinical-benefits-cybersecurity-risks-ai-innovations-and-regulatory-standards/